Literature DB >> 9021719

Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C.

R Fukuda1, N Ishimura, S Ishihara, A Chowdhury, N Morlyama, C Nogami, T Miyake, M Niigaki, A Tokuda, S Satoh, S Sakai, S Akagi, M Watanabe, S Fukumoto.   

Abstract

To investigate the relationship between intrahepatic cytokine expression and interferon (IFN) response in chronic hepatitis C [CH(C)], interleukin (IL)-1 beta, -2, -4, -6, -8, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha and TNF-beta mRNAs were investigated semiquantitatively by reverse transcription polymerase chain reaction using serial liver biopsies taken before and after IFN-alpha treatment from 24 patients with CH(C), including 12 responders and 12 non-responders. Before IFN treatment, IL-2, TNF-beta, IFN-gamma and IL-8 mRNA were associated with severe hepatitis activity whereas IL-4 mRNA was associated with weak hepatitis activity, regardless of IFN response. IL-2, TNF-beta and IFN-gamma mRNAs were significantly greater in IFN non-responders. After IFN treatment a complete response to IFN was significantly associated with the disappearance of these pro-inflammatory cytokines, whereas non-responders retained the expression of cytokine mRNA as before IFN treatment. Our results indicated that IFN-alpha treatment may modulate the intrahepatic cytokine network, and this may be one mechanism of IFN-alpha that reduces hepatitis activity, aside from an anti-viral effect. A difference in cytokine network may be involved in IFN response in CH(C).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9021719     DOI: 10.1111/j.1600-0676.1996.tb00768.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  20 in total

1.  Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.

Authors:  Jason T Blackard; Minhee Kang; Kenneth E Sherman; Margaret James Koziel; Marion G Peters; Raymond T Chung
Journal:  J Interferon Cytokine Res       Date:  2006-11       Impact factor: 2.607

2.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection.

Authors:  P H McGuinness; D Painter; S Davies; G W McCaughan
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.

Authors:  S J Polyak; K S Khabar; M Rezeiq; D R Gretch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 4.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

5.  Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.

Authors:  Zaigham Abbas; Tariq Moatter; Akber Hussainy; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

6.  Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.

Authors:  Curtis Cooper; Stephan Shafran; Susan Greenbloom; Robert Enns; John Farley; Nir Hilzenrat; Kurt Williams; Magdy Elkashab; Nabil Abadir; Manuela Neuman
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-08

7.  Viral factors associated with cytokine expression during HCV/HIV co-infection.

Authors:  Jason T Blackard; Minhee Kang; J Benjamin St Clair; Wenyu Lin; Yoshitaka Kamegaya; Kenneth E Sherman; Margaret James Koziel; Marion G Peters; Janet Andersen; Raymond T Chung
Journal:  J Interferon Cytokine Res       Date:  2007-04       Impact factor: 2.607

Review 8.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 9.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

Review 10.  Fibromyalgia, hepatitis C infection, and the cytokine connection.

Authors:  Mollie E Thompson; André Barkhuizen
Journal:  Curr Pain Headache Rep       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.